Omass Therapeutics Limited
Research and experimental development on biotechnology · Oxford
ActiveUnited KingdomIncorporated 2016Private Limited Company
Financial position
Accounts to 2020-12-31 · GBP · unknown scope
Net assets
£13,891,798
Cash
£10,057,644
Turnover
£0
Profit / loss
—
Current assets
£12,560,803
Creditors < 1 year
£2,270,030
Equity
£13,891,798
Average employees
28
Balance-sheet trend
GBP · unknownTwo periods with a known, matching scope are needed for a trend.
Financial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
| Reported figures | 2020-12-31GBP · unknown | 2019-12-31GBP · unknown |
|---|---|---|
| Balance sheet | ||
| Net assets | £13,891,798 | £9,090,038 |
| Equity | £13,891,798 | £9,090,038 |
| Assets | ||
| Fixed assets | £3,611,024 | £1,145,138 |
| Intangible assets | £1,193,859 | £0 |
| Property, plant & equipment | £2,141,636 | £1,145,138 |
| Current assets | £12,560,803 | £9,154,365 |
| Cash at bank | £10,057,644 | £7,830,084 |
| Debtors | £2,503,159 | £1,324,281 |
| Stock | £0 | £0 |
| Liabilities | ||
| Creditors within one year | £2,270,030 | £1,134,467 |
| Creditors after one year | £9,999 | £74,998 |
| Provisions | £0 | £0 |
| Net current assets | £10,290,773 | £8,019,898 |
| Assets less current liabilities | £13,901,797 | £9,165,036 |
| Profit & loss | ||
| Turnover | £0 | £42,500 |
| Gross profit | £0 | £42,500 |
| Operating profit | −£7,562,690 | −£5,119,449 |
| Profit before tax | −£7,557,464 | −£5,118,519 |
| People | ||
| Average employees | 28 | 17 |
| Source evidence | View filing | View filing |
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
0 outstanding chargesShow 1 satisfied / released
Fixed · created 2019-06-26 · satisfied 2022-12-22
—
Satisfied